This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

NCT06965803 | Recruiting

• 1 other identifier: STUDY00003936
• Study Type: observational
• Target: 37
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Conditions

Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

• Patient Satisfaction (using a 5-point likert scale)

  Glucose Monitoring Satisfaction Survey

  15 days

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

• Admitted patient with Type 1 or Type 2 diabetes.

You may qualify if:

• aged 18 or older
• diagnosed with Type 1 or Type 2 Diabetes who are on insulin
• able to speak and understand English language
• scheduled to receive a standard inpatient diabetes education consultation
• must not have used CGM in the six months prior to admission
• owns a smartphone
• demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program

You may not qualify if:

• those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
• non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.

Sponsors & Collaborators

• Cedars-Sinai Medical Center: lead

Study Sites (1)

Cedars-Sina Medical Center

Los Angeles, California, 90048, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Central Study Contacts

Mathew P Monterola, Doctor of Nursing Practice

CONTACT

3109677434; Mathew.Monterola@cshs.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Director, Clinical Support Programs

Study Record Dates

• First Submitted: May 2, 2025
• First Posted: May 11, 2025
• Study Start: October 1, 2025
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): December 30, 2026
• Last Updated: March 18, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)